KR880003896A - 환상지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도 - Google Patents

환상지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도 Download PDF

Info

Publication number
KR880003896A
KR880003896A KR1019870010070A KR870010070A KR880003896A KR 880003896 A KR880003896 A KR 880003896A KR 1019870010070 A KR1019870010070 A KR 1019870010070A KR 870010070 A KR870010070 A KR 870010070A KR 880003896 A KR880003896 A KR 880003896A
Authority
KR
South Korea
Prior art keywords
amino acid
group
compound according
ester
pharmaceuticals
Prior art date
Application number
KR1019870010070A
Other languages
English (en)
Other versions
KR940011902B1 (ko
Inventor
라뤼엘 끌로드
레빵 마르셀
레이니엘 베르나르
Original Assignee
빵메디까 소시에떼아노님
원본미기재
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 빵메디까 소시에떼아노님, 원본미기재 filed Critical 빵메디까 소시에떼아노님
Publication of KR880003896A publication Critical patent/KR880003896A/ko
Application granted granted Critical
Publication of KR940011902B1 publication Critical patent/KR940011902B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

내용 없음

Description

환상지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 하기 일반식(Ⅰ)에 따르는 환상지방족 알코올의 아미노산 에스테르
    상기식에서, R은 천연-아미노산 또는 메틸에스테르, 에틸에스테르 또는 1급 아미드와 같은 그의 단순 유도체의 잔기이고, Y는 수소, 아세틸, 프로피오닐, 벤조일기 또는 R과 함께 피로글루탐산(pyroglutamicacid) 에스테르의 일반식을 결정짓는 피롤리딘-2-링(pyrrolidin-2-ring)을 나타내며, A는 메틸, 에틸, 메틸렌, 에틸렌 및 에테닐 그룹에서 선택된 하나 이상의 알킬기에 의해 임의적으로 치환된 사이클로헥실, 사이클로헥세닐, 사이클로펜틸 및 사이클로펜테닐로 구성된 그룹에서 선택된 환상 지방족을 나타낸다.
  2. 재1항에 있어서, A가 사이클로헥실 그룹인 것을 특징으로 하는 화합물.
  3. 재1항에 있어서, A가 사이클로펜틸 그룹인 것을 특징으로 하는 화합물.
  4. 재1항에 있어서, 아미노산이 피로글루탐산인 것을 특징으로 하는 화합물.
  5. 제4항에 있어서, A가 3.3.5-트리메틸사이클로 헥실그룹인 것을 특징으로 하는 화합물.
  6. 제4항에 있어서, 3.3.5-트리메틸사이클로헥사놀이 90%이상의 시스 이성체 또는 트랜스 이성체를 함유하는 형태로 되어 있는 것을 특징으로 하는 화합물.
  7. 제1항에 있어서, 피로글루탐산이 L 배열로 되어 있는 것을 특징으로 하는 화합물.
  8. 필요하지 않은 반응성 그룹을 미리 방어한 아미노산을 보통 온도에서 촉매적 분량의 디메틸아미노피리딘의 존재하에 비활성 용매에서 시클로알카놀과 반응시키고 그 생성물을 크로마토그래피 또는 증류하여 정제하고 가수소분해에 의해 방어그룹, 바람직하기로는 벤질 옥시 카르보닐 그룹을 제거하는 것을 특징으로 하는 제1항에 따른 유도체의 제조방법.
  9. 순수한 상태 또는 약제학적으로 허용되는 산 또는 염기의 염의 형태로서 인간 또는 동물의 지혈증 질환을 치료하는데 쓰이는 제1항에 따른 최소한 하나의 유도체를 함유하는 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870010070A 1986-09-16 1987-09-11 환상 지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도 KR940011902B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR12915 1986-09-16
FR8612915A FR2603888B1 (fr) 1986-09-16 1986-09-16 Esters d'amino acides du trimethyl cyclohexanol, procede de preparation et utilisation comme medicaments
FR8612915 1986-09-16

Publications (2)

Publication Number Publication Date
KR880003896A true KR880003896A (ko) 1988-06-01
KR940011902B1 KR940011902B1 (ko) 1994-12-27

Family

ID=9338978

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870010070A KR940011902B1 (ko) 1986-09-16 1987-09-11 환상 지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도

Country Status (11)

Country Link
US (1) US5134157A (ko)
EP (1) EP0261017B1 (ko)
JP (1) JPS6383053A (ko)
KR (1) KR940011902B1 (ko)
AT (1) ATE61793T1 (ko)
AU (1) AU606611B2 (ko)
DE (1) DE3768747D1 (ko)
ES (1) ES2029846T3 (ko)
FR (1) FR2603888B1 (ko)
GR (1) GR3001645T3 (ko)
ZA (1) ZA876728B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236946A (en) * 1986-09-16 1993-08-17 Panmedica S.A. Amino acid esters of cycloaliphatic alcohols and their use in treating lipemic disorders
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
JP2909500B2 (ja) * 1989-03-23 1999-06-23 ベルレックス、ラボラトリーズ、レンコーポレイテッド 水溶性抗高脂質血症剤として有用な官能化側鎖を有するポリアミド
FR2654338A1 (fr) * 1989-11-13 1991-05-17 Panmedica Sa Agent de traitement de l'atherosclerose.
FR2677981A1 (fr) * 1991-06-19 1992-12-24 Panmedica Procede de preparation des formes isomeres pures d'esters d'aminoacides du -3,3,5-trimethylcyclohexanol et de la -3,3,5-trimethylcyclohexanone.
BRPI0519919A2 (pt) * 2004-12-15 2009-04-07 Solvay Pharm Gmbh composições farmacêuticas compreendendo inibidores da nep, inibidores do sistema de produção de endotelina endógena e inibidores da hmg coa redutase
US8019567B2 (en) 2007-09-17 2011-09-13 Ecofactor, Inc. System and method for evaluating changes in the efficiency of an HVAC system
US8010237B2 (en) 2008-07-07 2011-08-30 Ecofactor, Inc. System and method for using ramped setpoint temperature variation with networked thermostats to improve efficiency
US8180492B2 (en) 2008-07-14 2012-05-15 Ecofactor, Inc. System and method for using a networked electronic device as an occupancy sensor for an energy management system
US8740100B2 (en) 2009-05-11 2014-06-03 Ecofactor, Inc. System, method and apparatus for dynamically variable compressor delay in thermostat to reduce energy consumption
US8596550B2 (en) 2009-05-12 2013-12-03 Ecofactor, Inc. System, method and apparatus for identifying manual inputs to and adaptive programming of a thermostat
US8090477B1 (en) * 2010-08-20 2012-01-03 Ecofactor, Inc. System and method for optimizing use of plug-in air conditioners and portable heaters
US10048706B2 (en) 2012-06-14 2018-08-14 Ecofactor, Inc. System and method for optimizing use of individual HVAC units in multi-unit chiller-based systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE261228C (ko) *
NL75913C (ko) * 1900-01-01
GB729550A (en) * 1951-11-05 1955-05-11 Farmaceutici Italia A process for preparing cyclohexyl esters of ª‰-phenyl-ª‡-amino acids, and new products obtained thereby
BE693604A (ko) * 1966-02-04 1967-08-03
FR1517697A (fr) * 1966-03-15 1968-03-22 Leanord Nouveaux composés esters et amides de l'acide pyroglutamique, procédé pour leur fabrication, solvants à base de tels composés, et procédé d'extraction avec de tels solvants
GB1436329A (en) * 1972-08-07 1976-05-19 Unilever Ltd Esters of menthol and a heterocyclic carboxylic acid and their use in cosmetic preparations
LU68016A1 (ko) * 1973-07-13 1975-04-11
JPS5093920A (ko) * 1973-12-21 1975-07-26
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
US4452989A (en) * 1982-06-01 1984-06-05 Charles Of The Ritz Group Ltd. Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same
EP0154472B1 (en) * 1984-03-07 1989-10-11 Ajinomoto Co., Inc. Process for the production of l-aspartyl-l-phenylalanine ester
JPS60243073A (ja) * 1984-05-16 1985-12-03 Sumitomo Chem Co Ltd 光学活性アルコ−ル誘導体の製造法
GB8421112D0 (en) * 1984-08-20 1984-09-26 Unilever Plc Pyroglutamic acid esters
FR2572399B1 (fr) * 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
US4639443A (en) * 1985-03-01 1987-01-27 Hoechst-Roussel Pharmaceuticals Inc. Labdane compounds, pharmaceutical compositions and use
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use

Also Published As

Publication number Publication date
ZA876728B (en) 1988-03-14
EP0261017B1 (fr) 1991-03-20
US5134157A (en) 1992-07-28
DE3768747D1 (de) 1991-04-25
AU606611B2 (en) 1991-02-14
GR3001645T3 (en) 1992-11-23
FR2603888B1 (fr) 1990-12-21
ATE61793T1 (de) 1991-04-15
KR940011902B1 (ko) 1994-12-27
AU7776387A (en) 1988-03-24
ES2029846T3 (es) 1992-10-01
FR2603888A1 (fr) 1988-03-18
EP0261017A1 (fr) 1988-03-23
JPS6383053A (ja) 1988-04-13

Similar Documents

Publication Publication Date Title
DE69309047T2 (de) Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren
EP0131226B1 (de) Derivate der 2-Azabicyclo(3.1.0)hexan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie 2-Azabicyclo(3.1.0)hexan-Derivate als Zwischenprodukte und Verfahren zu deren Herstellung
KR880003896A (ko) 환상지방족 알코올의 아미노산 에스테르, 그 제조방법 및 약제로서의 그 용도
KR950702545A (ko) 약제로서의 헤테로시클릭 화합물(Heterocyclic compounds as pharmaceutical)
EP0527687A3 (fr) Nouveaux dérivés d'aryléthylamines, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
KR830006219A (ko) 아미노산 유도체의 제조방법
IE904555A1 (en) HIV Protease inhibitors useful for the treatment of AIDS
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
KR950014073A (ko) 이소퀴놀린
EA200301204A1 (ru) Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
EP0003056A1 (de) N-substituierte omega-Aminoalkanoyl-omega-aminoalkansäuren, ihre Verwendung und Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
ATE8047T1 (de) (2-oxo-3-tetrahydrothienylcarbamoyl)-alkylthioessigs[ure, ihre salze und ester, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
KR960000851B1 (ko) 비사이클릭 아미노 카복실산 유도체, 그의 제조 방법 및 중간 생성물, 및 그의 용도
DE3864691D1 (de) Thiazolidin-4-carbonsaeurederivat, seine herstellung und pharmazeutische zusammensetzungen, die dieses enthalten.
EA199800155A1 (ru) Новое соединение
HRP931025A2 (en) Amino acid derivatives
KR900017993A (ko) 거울상 이성체 글루타르아미드 이뇨제
KR920002141A (ko) 폴리옥시에틸렌소르비탄 단일 고급 지방산 에스테르에 의한 염증성 질병의 치료
EP0009777A1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
ES8304992A1 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
ATE66920T1 (de) Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten.
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
GB1581321A (en) Prostaglandins
RU94027564A (ru) Производные аминокислоты, смесь их изомеров или отдельные изомеры и их соли, способ их получения и фармацевтическая композиция
JPH04244076A (ja) ビタミンａ酸エステル化合物

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee